Patent details

Basic Information

Publication number:

EP3903826

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP211673389

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIOMOLECULE CONJUGATES

French Title of Invention:

CONJUGUÉS DE BIOMOLÉCULES

German Title of Invention:

BIOMOLEKÜLKONJUGATE

SPC Number:

Dates

Filing date:

03/12/2015

Grant date:

08/05/2024

EP Publication Date:

03/11/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/05/2024

EP B1 Publication Date:

08/05/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

03/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/05/2024

 

 

Name:

Celgene Corporation

Address:

Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

SCHWARTZ, Eric

Address:

United States (US)

2

Name:

CUERVO, Hernan

Address:

United States (US)

3

Name:

AUSTIN, Wesley

Address:

United States (US)

4

Name:

D'AGOSTINO, Laura Akullian

Address:

United States (US)

Priority

Priority Number:

201462087369 P

Priority Date:

04/12/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 47/54; A61K 47/68; A61K 31/5365; A61P 35/00; C07D 498/18; C07F 17/02;

Publication

European Patent Bulletin

Issue number:

202419

Publication date:

08/05/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages